The effects of melatonin on signaling pathways and molecules involved in glioma

Area of Science:

• Neuro-oncology
• Molecular Biology
• Cancer Research

Background:

• Glioblastoma is a highly invasive and malignant brain tumor with poor patient survival rates.
• Glioblastoma stem-like cells are implicated in tumor progression and treatment resistance.
• Identifying oncogenes and their regulatory molecules is crucial for improving glioblastoma treatment.

Purpose of the Study:

• To review the effects of melatonin on signaling pathways and molecules involved in glioma progression.
• To investigate melatonin's potential role in targeting glioblastoma stem-like cells.

Main Methods:

• Literature review of studies on melatonin, glioma, and associated signaling pathways.
• Analysis of molecular mechanisms underlying melatonin's effects on glioma cells.
• Synthesis of current research on melatonin's antioxidant and anti-apoptotic properties in the context of glioma.

Main Results:

• Melatonin exhibits antioxidant and anti-apoptotic effects, inhibiting malignant glioma cell proliferation.
• Melatonin influences various biological processes and signaling pathways critical to glioma development.
• Evidence suggests melatonin may target key molecules and pathways driving glioblastoma progression.

Conclusions:

• Melatonin demonstrates potential as a therapeutic agent in glioblastoma by modulating critical signaling pathways.
• Further research into melatonin's mechanisms could lead to novel treatment strategies for glioblastoma.
• Targeting melatonin's effects may help overcome treatment resistance associated with glioblastoma stem-like cells.